VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 134 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,959 | -7.7% | 27,833 | +43.2% | 0.00% | – |
| Q2 2023 | $462,454 | -2.5% | 19,439 | +4.2% | 0.00% | – |
| Q1 2023 | $474,457 | -91.7% | 18,650 | -90.4% | 0.00% | -100.0% |
| Q4 2022 | $5,682,425 | +23.5% | 194,537 | -13.3% | 0.00% | +100.0% |
| Q3 2022 | $4,601,000 | +3494.5% | 224,316 | +1932.2% | 0.00% | – |
| Q2 2022 | $128,000 | – | 11,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |